News|Articles|July 1, 2026

9 Endocrinology Headlines You Missed in June 2026

Catch up on major trial results, groundbreaking FDA decisions, and key clinician insights from major endocrinology conferences.

June was a very active month for endocrinology, with major US Food and Drug Administration (FDA) approvals and a pair of major conferences. The FDA granted clearance to new devices for type 1 diabetes (T1D) while the Endocrine Society (ENDO) Annual Meeting 2026 and the American Diabetes Association (ADA) Scientific Sessions 2026 brought with them a substantial number of major trials in obesity and type 2 diabetes (T2D).